LIGAND PHARMACEUTICALS INCORPORATED Cost, Direct Material
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Cost, Direct Material of $3.21 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostDirectMaterial · last filed 2026-08-07
- LIGAND PHARMACEUTICALS INCORPORATED cost, direct material for the quarter ending 2026-06-30 was $3.21M, a 10.56% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED cost, direct material for the quarter ending 2026-03-31 was $3.27M, a 32.50% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED cost, direct material for the quarter ending 2025-12-31 was $2.99M, a 5.46% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED cost, direct material for the quarter ending 2025-09-30 was $3.80M, a 55.21% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED cost, direct material for fiscal 2025 was $14.55M, a 31.38% increase from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED cost, direct material for fiscal 2024 was $11.07M, a 5.35% increase from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED cost, direct material for fiscal 2023 was $10.51M, a 80.10% decline from fiscal 2022.
- LIGAND PHARMACEUTICALS INCORPORATED cost, direct material for fiscal 2022 was $52.83M, a 15.04% decline from fiscal 2021.
| Period end | Cost, Direct Material 3 month | Cost, Direct Material 6 month | Cost, Direct Material 9 month | Cost, Direct Material 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.21M 10-Q · filed 2026-08-07 | $6.49M 10-Q · filed 2026-08-07 | $9.48M derived: sum of 3 quarters · filed 2026-08-07 | $13.28M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $3.27M 10-Q · filed 2026-05-08 | $6.26M derived: sum of 2 quarters · filed 2026-05-08 | $10.07M derived: sum of 3 quarters · filed 2026-05-08 | $12.97M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $6.79M derived: sum of 2 quarters · filed 2026-02-27 | $9.70M derived: sum of 3 quarters · filed 2026-08-07 | $14.55M 10-K · filed 2026-02-27 |
| 2025-09-30 | $3.80M 10-Q · filed 2025-11-07 | $6.71M derived: sum of 2 quarters · filed 2026-08-07 | $11.56M 10-Q · filed 2025-11-07 | $14.39M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $2.91M 10-Q · filed 2026-08-07 | $7.76M 10-Q · filed 2026-08-07 | $10.59M derived: sum of 3 quarters · filed 2026-08-07 | $13.04M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $4.85M 10-Q · filed 2026-05-08 | $7.69M derived: sum of 2 quarters · filed 2026-05-08 | $10.13M derived: sum of 3 quarters · filed 2026-05-08 | $13.04M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $5.29M derived: sum of 2 quarters · filed 2026-02-27 | $8.19M derived: sum of 3 quarters · filed 2026-02-27 | $11.07M 10-K · filed 2026-02-27 |
| 2024-09-30 | $2.45M 10-Q · filed 2025-11-07 | $5.36M derived: sum of 2 quarters · filed 2025-11-07 | $8.24M 10-Q · filed 2025-11-07 | $9.88M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $2.91M 10-Q · filed 2025-08-08 | $5.79M 10-Q · filed 2025-08-08 | $7.43M derived: sum of 3 quarters · filed 2026-02-27 | $10.91M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $2.88M 10-Q · filed 2025-05-09 | $4.52M derived: sum of 2 quarters · filed 2026-02-27 | $8.01M derived: sum of 3 quarters · filed 2026-02-27 | $9.68M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $5.13M derived: sum of 2 quarters · filed 2026-02-27 | $6.79M derived: sum of 3 quarters · filed 2026-02-27 | $10.51M 10-K · filed 2026-02-27 |
| 2023-09-30 | $3.48M 10-Q · filed 2024-11-08 | $5.15M derived: sum of 2 quarters · filed 2024-11-08 | $8.87M 10-Q · filed 2024-11-08 | $30.48M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $1.67M 10-Q · filed 2024-08-07 | $5.39M 10-Q · filed 2024-08-07 | $27.00M derived: sum of 3 quarters · filed 2025-02-28 | $41.15M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $3.72M 10-Q · filed 2024-05-08 | $25.33M derived: sum of 2 quarters · filed 2025-02-28 | $39.48M derived: sum of 3 quarters · filed 2025-02-28 | $51.84M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $21.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $35.77M derived: sum of 2 quarters · filed 2025-02-28 | $48.13M derived: sum of 3 quarters · filed 2025-02-28 | $52.83M 10-K · filed 2025-02-28 |
| 2022-09-30 | $14.15M 10-Q · filed 2023-11-09 | $26.51M derived: sum of 2 quarters · filed 2023-11-09 | $31.21M 10-Q · filed 2023-11-09 | $43.20M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $12.36M 10-Q · filed 2023-08-09 | $17.06M 10-Q · filed 2023-08-09 | $29.04M derived: sum of 3 quarters · filed 2024-02-29 | $40.49M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $4.70M 10-Q · filed 2023-05-08 | $16.68M derived: sum of 2 quarters · filed 2024-02-29 | $28.13M derived: sum of 3 quarters · filed 2024-02-29 | $58.72M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $11.98M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $23.43M derived: sum of 2 quarters · filed 2024-02-29 | $54.02M derived: sum of 3 quarters · filed 2024-02-29 | $62.18M 10-K · filed 2024-02-29 |
| 2021-09-30 | $11.45M 10-Q · filed 2022-11-08 | $42.04M derived: sum of 2 quarters · filed 2022-11-08 | $50.19M 10-Q · filed 2022-11-08 | $61.93M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $30.59M 10-Q · filed 2022-08-09 | $38.75M 10-Q · filed 2022-08-09 | $50.48M derived: sum of 3 quarters · filed 2023-02-28 | $56.84M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $8.15M 10-Q · filed 2022-05-09 | $19.89M derived: sum of 2 quarters · filed 2023-02-28 | $26.25M derived: sum of 3 quarters · filed 2023-02-28 | $33.89M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $11.74M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $18.09M derived: sum of 2 quarters · filed 2023-02-28 | $25.74M derived: sum of 3 quarters · filed 2023-02-28 | $30.42M 10-K · filed 2023-02-28 |
| 2020-09-30 | $6.35M 10-Q · filed 2021-11-09 | $14.00M derived: sum of 2 quarters · filed 2021-11-09 | $18.68M 10-Q · filed 2021-11-09 | $20.62M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $7.64M 10-Q · filed 2021-08-03 | $12.33M 10-Q · filed 2021-08-03 | $14.26M derived: sum of 3 quarters · filed 2022-02-28 | $17.41M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $4.68M 10-Q · filed 2021-05-06 | $6.62M derived: sum of 2 quarters · filed 2022-02-28 | $9.77M derived: sum of 3 quarters · filed 2022-02-28 | $12.17M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $5.08M derived: sum of 2 quarters · filed 2022-02-28 | $7.49M derived: sum of 3 quarters · filed 2022-02-28 | $11.35M 10-K · filed 2022-02-28 |
| 2019-09-30 | $3.15M 10-Q · filed 2020-11-06 | $5.55M derived: sum of 2 quarters · filed 2020-11-06 | $9.41M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $2.40M 10-Q · filed 2020-08-07 | $6.26M 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $3.86M 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | $6.34M 10-K · filed 2021-02-24 | |||
| 2017-12-31 | $5.37M 10-K · filed 2020-02-27 |